|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
A Baldness Update from Histogen; Sequenom Agrees to Settle a Suit; the Life Sciences Job Outlook Improves & More San Diego Life Sciences News
|
Denise Gellene |
01/21/10 |
San Diego
|
|
Sequenom Settles Shareholder Lawsuit for $14M, Plus Stock
|
Luke Timmerman |
01/15/10 |
San Diego
|
|
Biogen Idec CEO Stepping Down, Ambrx Focuses on Empowered Antibodies, Intellikine Testing First Drug Candidate, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
01/07/10 |
San Diego
|
|
Sequenom Settles SensiGen Claims
|
Bruce V. Bigelow |
01/04/10 |
San Diego
|
|
Ambit Signs Big Deal With Astellas, Xenomics Alleges Fraud at Sequenom, Arena Seeks FDA Approval for Weight-Loss Drug & More San Diego Life Sciences News
|
Bruce V. Bigelow |
12/24/09 |
San Diego
|
|
Scandal, Swine Flu, Shareholder Disputes, and More: 2009 Was Quite a Year for San Diego’s Life Sciences Industry
|
Denise Gellene |
12/22/09 |
San Diego
|
|
Sequenom Down Syndrome Results “Deliberately Doctored,” Says Partner Xenomics
|
Luke Timmerman |
12/17/09 |
San Diego
|
|
Sequenom Looks to Prolong Operations as Available Cash Runs Low
|
Denise Gellene |
11/10/09 |
San Diego
|
|
Amylin Forms Global Alliance in Obesity Drug Development; TEDMED’s Show Will Go On, Sequenom Sued for Civil Fraud, & More San Diego Biotech News
|
Bruce V. Bigelow |
11/05/09 |
San Diego
|
|
New York Biotech Sues Sequenom for Fraud
|
Denise Gellene |
10/29/09 |
San Diego
|
|
UK’s Enigma Looks to San Diego, Life Gets Sweeter for Senomyx, Arena Says Obesity Drug Is Not “Wimpy,” & More San Diego Life Sciences News
|
Denise Gellene |
10/29/09 |
San Diego
|
|
Sequenom Settles Ibis Dispute
|
Luke Timmerman |
10/27/09 |
San Diego
|
|
Justice Department Joins Sequenom Probe, Accumetrics Raises $16.5, Transdel’s Topical Pain Reliever Gets Mixed Results, & More San Diego Life Sciences News
|
Denise Gellene |
10/08/09 |
San Diego
|
|
Sequenom Meets With FBI, U.S. Attorney’s Office Investigators
|
Luke Timmerman |
10/05/09 |
San Diego
|
|
Sequenom Starts Over After Purge, Patent Lawsuits Flying Over Gene Sequencing Technologies, Zogenix Prepares for Needle-Free Injections, & More San Diego Biotech News
|
Bruce V. Bigelow |
10/01/09 |
San Diego
|
|
Sequenom Shares Tank After Executives Ousted Over Data Mishandling
|
Luke Timmerman |
09/28/09 |
San Diego
|
|
Sequenom Ousts CEO Harry Stylli, After Investigating Mishandling of Down Syndrome Test
|
Luke Timmerman |
09/28/09 |
San Diego
|
|
The San Diego Biotech Survival Index: Local Firms Make Strong Rebound In First Half of 2009
|
Luke Timmerman |
09/23/09 |
San Diego
|
|
Domain Raises a $500M VC Fund, Dissident Prods Amylin Again, Avanir Passes Pivotal Test, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
08/13/09 |
San Diego
|
|
Sequenom Maintains Tight Lid on “Mishandled Data” of Key Diagnostic Test
|
Denise Gellene |
08/11/09 |
San Diego
|
|
Sequenom Discloses SEC Probe, How Evoke Pharma Got its Drug, Illumina Sales Fall Short, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
07/02/09 |
San Diego
|
|
SEC Opens Probe of Sequenom Research
|
Bruce V. Bigelow |
07/01/09 |
San Diego
|
|
Qualcomm and Broadcom Sign Patent Peace Treaty, A Green Day for San Diego (as in Algae, Not Rock n’ Roll), Corporate Crisis Hits Sequenom, & Other San Diego BizTech News
|
Bruce V. Bigelow |
05/04/09 |
San Diego
|
|
Sequenom Discloses Test Data Mishandled; Shares Plunge
|
Bruce V. Bigelow |
04/29/09 |
San Diego
|
|
No Resolution in Amylin’s Talks With Dissident Investors Carl Icahn and Eastbourne Capital, Anadys Sees Promise in Treatment for Hepatitis C, Chumby Makes Moves into Europe, & Other San Diego BizTech News
|
Juha-Pekka Tikka |
04/27/09 |
San Diego
|
|
Sequenom Reorganizes its Genetic Analysis Business, Trims Workforce
|
Bruce V. Bigelow |
04/23/09 |
San Diego
|
|
Charting Startups in the Downturn, San Diego’s Biotech Survival Index (Part Deux), Court Dismisses Federal Patent Suit Against Qualcomm, & More SD BizTech News
|
Bruce V. Bigelow |
03/23/09 |
San Diego
|
|
The San Diego Biotech Survival Index 2: Clinging to Cash in the Downturn
|
Luke Timmerman |
03/20/09 |
San Diego
|
|
Harvard Researcher to Helm Merck’s Cancer Research, Genzyme Acquires Certain Exact Sciences Assets, NeurAxon Out to Axe Migraines, & More Boston-Area Life Sciences
|
Rebecca Zacks |
02/04/09 |
Boston
|
|
Qualcomm’s MediaFLO Depends on DTV Switchover, Carl Icahn Raises Stakes for Amylin, Slacker Gets $5M, & More San Diego BizTech News
|
Bruce V. Bigelow |
02/02/09 |
San Diego
|
|
Page 2 of
3 |
« previous page · next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.